top of page
Aravax is a clinical-stage biotechnology company developing safe, convenient and disease-modifying treatments for peanut and other food allergies.
About Aravax

Aravax is a clinical-stage biotechnology company developing safe, convenient and disease-modifying treatments for food allergies.

​

Aravax uses proprietary platform technology to precisely reset the immune system to tolerate allergens, without provoking severe reactions during treatment

Clinical Trials

Phase 1 clinical trials of Aravax's lead product for peanut allergy, PVX108, have been successfully completed.

​

Phase 2 trials of PVX108 have commenced in peanut allergic adolescents and children and are now recruiting at clinics in Australia and the United States.

bottom of page